检索

期
标题
作者
卷 96, 编号 4 (2024): Issues of diagnostics of internal diseases
Status and trends of legislative and regulatory regulation of off-label use of drugs: A review
Zakharochkina E., Ryazhenov V., Smolyarchuk E., Kudlay D., Bekhorashvili N., Zaveryachev S., Sologova S.
PDF
(Rus)
卷 87, 编号 5 (2015)
Biological agents and fracture risk
Vetkova E., Dydykina I., Nasonov E.
卷 93, 编号 10 (2021)
Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy
Demidova T., Lobanova K., Perekhodov S., Antsiferov M., Oynotkinova O.
PDF
(Rus)
卷 96, 编号 5 (2024): Issues of rheumatology
Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice
Potapova A., Karateev A., Polishchuk E., Filatova E., Amirdzhanova V., Lila A.
PDF
(Rus)
卷 88, 编号 12 (2016)
Prospects for rheumatoid arthritis pharmacotherapy: New opportunities and recommendations
Nasonov E.
PDF
(Rus)
卷 97, 编号 5 (2025): Issues of rheumatology
To the problem of extended serological testing for viral hepatitis B in rheumatoid arthritis patients
Gridneva G., Belov B., Verizhnikova Z., Aronova E., Samarkina E., Panevin T., Lisitsyna T., Lukina G.
PDF
(Rus)
卷 94, 编号 1 (2022)
Treatment of patients with arterial hypertension in clinical practice in 2010–2020 (according to the national register of hypertension)
Aksenova A., Oschepkova E., Chazova I.
PDF
(Rus)
卷 91, 编号 6 (2019)
Recent advances in diagnosis and management of atrial fibrillation
Mironov N., Laiovich L., Mironova E., Sharf T., Aparina O., Mironova N., Stukalova O., Yuricheva Y., Sokolov S., Novikov I., Maykov E., Pevzner A., Golitsyn S.
PDF
(Rus)
卷 92, 编号 3 (2020)
The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)
Mariandyshev A., Khokhlov A., Smerdin S., Shcherbakova V., Igumnova O., Ozerova I., Bolgarina A., Nikitina N.
PDF
(Rus)
卷 91, 编号 11 (2019)
Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
Malov V., Ubeeva E., Ubeeva I., Nikolaev S., Umbetova K.
PDF
(Rus)
卷 90, 编号 8 (2018)
Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases
Zavodovsky B., Sivordova L.
PDF
(Rus)
卷 89, 编号 5 (2017)
New horizons in the use of biological agents during pregnancy in patients with rheumatic disease
Shesternya P., Petrova M., Vasilyeva A.
PDF
(Rus)
卷 88, 编号 6 (2016)
Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs
Milovanov Y., Fomin V., Milovanova L.
PDF
(Rus)
卷 87, 编号 8 (2015)
Use of biological therapy in patients with rheumatoid arthritis in the Republic of Kazakhstan
Nogaeva M., Amanzholova A.
卷 86, 编号 12 (2014)
Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis
Gaĭdukova I., Rebrov A., Nam I., Kirsanova N.
卷 86, 编号 1 (2014)
Current possibilities of correcting subchondral bone resorption as a major pathogenetic factor for progressive osteoarthrosis
Naumov A.
卷 84, 编号 12 (2012)
The specific features of copper and manganese metabolism in the use of iron-containing preparations
Zaĭtseva I., Nasolodin V., Zaĭtsev O., Gladkikh I., Dvorkin V.
卷 83, 编号 8 (2011)
Diagnosis and treatment of gastroesophageal reflux disease
Trukhmanov A., Trukhmanov A.
卷 78, 编号 12 (2003)
Dislipidemia treatment with original and generic statins: clinical and cost-effect efficacy, safety
Olbinskaya L., Danilogorskaya Y.
卷 97, 编号 4 (2025): Вопросы диагностики
Steroid-sparing effect of levilimab in rheumatoid arthritis in real practice
Ivanova L., Akulinushkina E., Vedekhina A., Garaeva N., Rashitova A., Taratorkin N.
PDF
(Rus)
卷 96, 编号 2 (2024): Issues of gastroenterology
Fixed combination of non-steroidal anti-inflammatory drug and muscle relaxant as the basis for rational therapy of pain syndromes: A review
Putilina M.
PDF
(Rus)
卷 93, 编号 11 (2021)
CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups
Abdullaev S., Denisenko N., Mirzaev K., Shuev G., Sozaeva Z., Kachanova A., Mammaev S., Kasaeva E., Gafurov D., Grishina E., Sychev D.
PDF
(Rus)
卷 92, 编号 11 (2020)
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years
Andreev D., Maev I., Kucheryavyy Y.
PDF
(Rus)
卷 92, 编号 2 (2020)
The long-term prospective study of patients with liver cirrhosis after elimination of the hepatitis C virus
Nabatchikova E., Abdurakhmanov D., Nikulkina E., Rozina T., Tanaschuk E., Nikiforova N., Adonyeva V., Moiseev S.
PDF
(Rus)
卷 91, 编号 8 (2019)
Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem
Osadchuk A., Davydkin I., Gricenko T., Osadchuk M.
PDF
(Rus)
卷 90, 编号 2 (2018)
Personalized medicine in the treatment of inflammatory bowel diseases
Parfenov A., Knyazev O., Kagramanova A., Fadeeva N.
PDF
(Rus)
卷 89, 编号 5 (2017)
Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study
Gaydukova I., Khondkaryan E., Aparkina A., Rebrov A.
PDF
(Rus)
卷 88, 编号 5 (2016)
The problem of cardiac safety of nonsteroidal anti-inflammatory drugs
Shostak N., Klimenko A., Demidova N., Kondrashov A.
PDF
(Rus)
卷 86, 编号 8 (2014)
Use of antihistamines in a physician's clinical practice
Luss L.
卷 85, 编号 9 (2013)
On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (Exforge - Clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)
Chazova I., Martyniuk T.
卷 84, 编号 9 (2012)
Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension
Martyniuk T., Arkhipova O., Kobal' E., Danilov N., Chazova I.
卷 83, 编号 5 (2011)
Current knowledge about pathogenesis and treatment of arterial hypertension in rheumatoid arthritis
Novikova D., Popkova T., Nasonov E., Novikova D., Popkova T., Nasonov E.
卷 78, 编号 5 (2003)
Gold preparations in therapy of rheumatoid and psoriatic arthritis
Nasonova V., Lukina G., Sigidin Y., Badokin V.
卷 97, 编号 5 (2025): Issues of rheumatology
Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century
Nasonov E.
PDF
(Rus)
卷 95, 编号 12 (2023)
Real-world experience with netakimab in the treatment of spondyloarthritis
Meshkov A., Vorobyeva N., Ostapenko V., Pykhtina V., Ruzanova V., Perlova O., Kordyukova I., Naumov A., Khovasova N., Tkacheva O.
PDF
(Rus)
卷 93, 编号 12 (2021)
Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations
Shavlovskaya O.
PDF
(Rus)
卷 92, 编号 8 (2020)
Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results
Maev I., Andreev D., Govorun V., Ilina E., Kucheryavyy Y., Oganesian T., Melnikova E., Zayratyants O., Parfenova T., Dzhedzheia L., Kirillova N., Maevskaya E., Fomenko A., Lobanova E., Zaborovskii A., Kriukov K.
PDF
(Rus)
卷 91, 编号 12 (2019)
The clinical status and treatment options for osteoarthritis in patients with frailty
Naumov A., Khovasova N., Moroz V., Tkacheva O., Shavlovskaya O.
PDF
(Rus)
卷 91, 编号 5 (2019)
Vitamin D - prognostic marker of the risk of exacerbation in patients older than 60 years with osteoarthritis of the knee (results of the observation program DIANA)
Zolotovskaya I., Davydkin I.
PDF
(Rus)
卷 90, 编号 6 (2018)
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy)
Karateev A., Pogozheva E., Filatova E., Amirjanova V., Lila A., Antipova O., Babaeva A., Volkorezova A., Davydova A., Davtyan V., Zonova E., Ivanova O., Kalinina N., Kiseleva N., Knyazeva L., Kulikov A., Nesmeyanova O., Mazurov V., Masneva L., Menshikova L., Obuhova I., Otteva E., Salnikova T., Shchendrygin I., Yakupova S.
PDF
(Rus)
卷 88, 编号 12 (2016)
Meloxicam in Russia: 20 years together
Karateev A., Nasonov E.
PDF
(Rus)
卷 88, 编号 5 (2016)
Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis
Popkova T., Novikova D., Nasonov E.
PDF
(Rus)
卷 87, 编号 8 (2015)
Clinical pharmacology and pharmacotherapy: Problems and disputable issues
Moiseev V., Kobalava Z.
卷 86, 编号 8 (2014)
Pathogenetic approaches to treating constipations
Luzina E.
卷 85, 编号 5 (2013)
Strategy for the use of chondroprotectors in osteoarthrosis
Noskov S., Lavrukhina A., Shirokova K., Prianichnikova A.
卷 84, 编号 8 (2012)
Diabetes mellitus is an independent risk factor for cardiovascular disease
Ametov A., Kulidzhanian N.
卷 81, 编号 8 (2009)
Clinical experience with infliximab administration in patients with rheumatoid arthritis by Russian register data
Lukina G., Sigidin Y., Nasonov E., Lukina G., Sigidin Y., Nasonov E.
卷 78, 编号 5 (2003)
Gastrointestinal hemorrhages as complications of gastropathies associated with intake of nonsteroid anti-inflammatory drugs
Shostak N., Ryabkova A., Savelyev V., Malyarova L.
卷 97, 编号 1 (2025): Поликлинические проблемы и организация медицинской помощи
A systematic review on the safety and efficacy of metamizole sodium as a therapy for the treatment of fever in children and adults
Malyavin A., Babak S., Zaplatnikov A., Bulgakova V., Garusova M., Ilyukhina M.
PDF
(Rus)
卷 95, 编号 12 (2023)
Autoimmunity in rheumatology: A review
Nasonov E.
PDF
(Rus)
1 - 50 的 117 信息 1 2 3 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语